Frequently Asked Questions
The market is segmented based on , By Drug (Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Others), Indication (Myocardial Infraction, Percutaneous Coronary Interventions, Arterial Thrombosis, Others), Route of Administration (Oral, Injectable), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.
.
The Global Antiplatelet Drugs Market size was valued at USD 2.18 USD Billion in 2022.
The Global Antiplatelet Drugs Market is projected to grow at a CAGR of 8.15% during the forecast period of 2023 to 2030.
The major players operating in the market include F. Hoffmann, La Roche , Mylan N.V., Teva Pharmaceutical Industries , Sanofi, Pfizer , GlaxoSmithKline plc, Novartis AG, Sun Pharmaceutical Industries , Bayer AG, AstraZeneca, Johnson & Johnson Private Limited, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Company, Merck & Co. , DAIICHI SANKYO COMPANY LIMITED, Otsuka America Pharmaceutical , Lilly, AbbVie , Genentech , Baxter, Bausch Health Companies .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
